Skip to main content
SEP ANALYTICAL (SHANGHAI) CO., LTD. logo

SEP ANALYTICAL (SHANGHAI) CO., LTD. — Investor Relations & Filings

Ticker · 301228 ISIN · CNE1000057C6 Shenzhen Stock Exchange Manufacturing
Filings indexed 609 across all filing types
Latest filing 2022-01-10 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301228

About SEP ANALYTICAL (SHANGHAI) CO., LTD.

https://www.sepchina.cn

SEP Analytical (Shanghai) Co., Ltd. specializes in the provision of high-performance chromatography consumables and analytical laboratory equipment. The company’s core portfolio includes high-performance liquid chromatography (HPLC) columns, gas chromatography (GC) columns, and solid-phase extraction (SPE) products. It also supplies a wide range of laboratory essentials such as vials, caps, and syringe filters. These products are engineered to support precise chemical analysis across various sectors, including pharmaceutical research, environmental testing, and food safety. The company focuses on delivering reliable separation solutions that enhance the sensitivity and reproducibility of analytical workflows. Through continuous technical innovation, SEP Analytical provides specialized tools designed to meet the rigorous demands of modern laboratory environments and complex sample matrices.

Recent filings

Filing Released Lang Actions
国浩律师(杭州)事务所关于公司首次公开发行股票并在创业板上市的补充法律意见书(一)
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding the initial public offering (IPO) and listing of a company on the ChiNext board (创业板). It includes extensive legal due diligence, responses to regulatory inquiry letters (审核问询函), and verification of shareholder qualifications, equity structure, and compliance with securities laws. The document references audit reports and internal control reports but is primarily a legal opinion supplementing previous legal opinions and work reports related to the IPO process. It is not a financial report, earnings release, or management discussion but a legal compliance and due diligence document related to the IPO process. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and miscellaneous filings that do not fit other categories.
2022-01-10 Chinese
关于公司非经常性损益的鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "非经常性损益明细表审核报告" which translates to "Non-recurring Profit and Loss Detail Audit Report." It is issued by a certified public accounting firm and includes audit opinions on the non-recurring profit and loss details for multiple years (2018, 2019, 2020, and the first half of 2021). The document contains detailed financial data and audit opinions, indicating it is a standalone audit report focused on a specific financial statement (non-recurring profit and loss details). It is not a full annual report or interim report but a specialized audit report. The presence of audit firm details, signatures of certified public accountants, and audit standards references further confirm this classification. The document length is substantial (15,000 characters), and it contains actual financial data and audit conclusions, so it is not merely an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). H1 2021
2022-01-10 Chinese
与投资者保护相关的承诺
Regulatory Filings Classification · 95% confidence The document consists of multiple detailed commitments and pledges by the issuer, its controlling shareholders, directors, supervisors, senior management, and shareholders regarding voluntary lock-up of shares, restrictions on share transfers, and compliance with relevant laws and regulations. It includes specific promises about shareholding and share transfer restrictions, as well as consequences for non-compliance. The content is focused on declarations and undertakings related to shareholding and lock-up commitments rather than financial results, management changes, or legal proceedings. It is not a financial report, earnings release, or management discussion. It is also not a proxy solicitation or voting results announcement. The document is a formal set of commitments by key stakeholders about share lock-up and related obligations, which fits best under the category of Regulatory Filings (RNS) as it is a regulatory disclosure of commitments and compliance undertakings that do not fit other specific categories.
2022-01-10 Chinese
首次公开发行股票并在创业板上市提示公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial public offering (IPO) of shares by 实朴检测技术(上海)股份有限公司 on the Shenzhen Stock Exchange's Growth Enterprise Market (创业板). It includes information about the issuance process, subscription dates, pricing, investor eligibility, allotment, payment, and risk warnings. The document is not a financial report, earnings release, or management discussion, but rather a formal notice about the capital raising event and share issuance. It is not a brief summary or a presentation but a comprehensive announcement related to the company's capital issuance and listing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (8089 characters) and content confirm it is a full announcement, not just a report publication announcement or regulatory filing.
2022-01-10 Chinese
首次公开发行股票并在创业板上市招股意向书
Capital/Financing Update Classification · 95% confidence The document is a 招股意向书 (Prospectus or Offering Intention Document) for an initial public offering (IPO) and listing on the Shenzhen Stock Exchange's ChiNext board. It contains detailed information about the stock issuance, risk factors, financial data, management commitments, and company operations. It is not a typical financial report like an annual or interim report, nor is it a simple announcement. The document is a detailed offering prospectus related to capital raising and listing. According to the filing definitions, updates on company fundraising and capital structure changes fall under Capital/Financing Update (CAP). Therefore, this document should be classified as a Capital/Financing Update (CAP).
2022-01-10 Chinese
首次公开发行股票并在创业板上市初步询价及推介公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial public offering (IPO) of a company named 实朴检测技术(上海)股份有限公司 on the ChiNext board (创业板) of the Shenzhen Stock Exchange. It includes extensive information about the IPO process, including preliminary inquiry, pricing, subscription procedures, investor qualifications, allotment, lock-up periods, and important dates related to the offering. The document references regulatory approvals from the China Securities Regulatory Commission (CSRC) and Shenzhen Stock Exchange rules, and it outlines the underwriting and subscription arrangements. The content is focused on the IPO issuance process and investor instructions rather than financial results or management commentary. It is not a financial report, earnings release, or management discussion. It is also not a simple announcement of a report publication but a comprehensive offering document. Therefore, the document fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as IPOs.
2022-01-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.